title: Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials?
authors: Medical Statistician (retired), London, United Kingdom. roger.ahern@icloud.com.
authors: Roger P
authors: RP
authors: A'Hern
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods*; D018450:Disease Progression; D018572:Disease-Free Survival; D023381:Endpoint Determination; D006801:Humans; D008495:Medical Oncology / Q000379:methods*; D009369:Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000628:therapy*; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome